AUD 0.2
(11.43%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 8.38 Million AUD | -55.84% |
2023 | 18.99 Million AUD | -28.46% |
2022 | 26.54 Million AUD | -11.43% |
2021 | 29.97 Million AUD | 71.47% |
2020 | 17.48 Million AUD | 42.7% |
2019 | 12.24 Million AUD | -24.07% |
2018 | 16.13 Million AUD | 13.18% |
2017 | 14.25 Million AUD | 57.84% |
2016 | 9.03 Million AUD | -1.04% |
2015 | 9.12 Million AUD | -8.07% |
2014 | 9.92 Million AUD | 453.73% |
2013 | 1.79 Million AUD | 76.29% |
2012 | 1.01 Million AUD | -16.51% |
2011 | 1.21 Million AUD | -2.48% |
2010 | 1.24 Million AUD | -12.07% |
2009 | 1.42 Million AUD | -38.98% |
2008 | 2.32 Million AUD | -34.56% |
2007 | 3.55 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 13.45 Million AUD | 0.0% |
2024 Q4 | 8.38 Million AUD | 0.0% |
2024 FY | 8.38 Million AUD | -55.84% |
2023 FY | 18.99 Million AUD | -28.46% |
2023 Q4 | 18.99 Million AUD | 0.0% |
2023 Q2 | 20.52 Million AUD | 0.0% |
2022 Q2 | 29.53 Million AUD | 0.0% |
2022 FY | 26.54 Million AUD | -11.43% |
2022 Q4 | 26.54 Million AUD | 0.0% |
2021 Q2 | 28.1 Million AUD | 0.0% |
2021 Q4 | 29.97 Million AUD | 0.0% |
2021 FY | 29.97 Million AUD | 71.47% |
2020 Q4 | 17.48 Million AUD | 0.0% |
2020 FY | 17.48 Million AUD | 42.7% |
2020 Q2 | 10.82 Million AUD | 0.0% |
2019 Q2 | 15.88 Million AUD | 0.0% |
2019 FY | 12.24 Million AUD | -24.07% |
2019 Q4 | 12.24 Million AUD | 0.0% |
2018 FY | 16.13 Million AUD | 13.18% |
2018 Q2 | 12.58 Million AUD | 0.0% |
2018 Q4 | 16.13 Million AUD | 0.0% |
2017 Q2 | 7.9 Million AUD | 0.0% |
2017 Q4 | 14.25 Million AUD | 0.0% |
2017 FY | 14.25 Million AUD | 57.84% |
2016 Q2 | 11.58 Million AUD | 0.0% |
2016 Q4 | 9.03 Million AUD | 0.0% |
2016 FY | 9.03 Million AUD | -1.04% |
2015 Q2 | 11.02 Million AUD | 0.0% |
2015 Q4 | 9.12 Million AUD | 0.0% |
2015 FY | 9.12 Million AUD | -8.07% |
2014 FY | 9.92 Million AUD | 453.73% |
2014 Q2 | 11.09 Million AUD | 0.0% |
2014 Q4 | 9.92 Million AUD | 0.0% |
2013 Q2 | 2.26 Million AUD | 0.0% |
2013 FY | 1.79 Million AUD | 76.29% |
2013 Q4 | 1.79 Million AUD | 0.0% |
2013 Q3 | 1.79 Million AUD | -20.96% |
2013 Q1 | 2.26 Million AUD | 123.02% |
2012 FY | 1.01 Million AUD | -16.51% |
2012 Q4 | 1.01 Million AUD | 0.0% |
2011 Q4 | 1.21 Million AUD | 0.0% |
2011 FY | 1.21 Million AUD | -2.48% |
2010 FY | 1.24 Million AUD | -12.07% |
2010 Q4 | 1.24 Million AUD | 0.0% |
2009 FY | 1.42 Million AUD | -38.98% |
2009 Q4 | 1.42 Million AUD | 0.0% |
2008 Q4 | 2.32 Million AUD | 0.0% |
2008 FY | 2.32 Million AUD | -34.56% |
2007 FY | 3.55 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
EZZ Life Science Holdings Limited | 25.55 Million AUD | 67.172% |
Anatara Lifesciences Ltd | 1.67 Million AUD | -401.865% |
Zelira Therapeutics Limited | 5.18 Million AUD | -61.829% |
Biome Australia Limited | 8.27 Million AUD | -1.347% |
Patrys Limited | 4.16 Million AUD | -101.565% |
Orthocell Limited | 26.61 Million AUD | 68.483% |
Imugene Limited | 151.39 Million AUD | 94.459% |
Noxopharm Limited | 6.78 Million AUD | -23.653% |
PYC Therapeutics Limited | 91.23 Million AUD | 90.806% |
Chimeric Therapeutics Limited | 15.27 Million AUD | 45.078% |
Prescient Therapeutics Limited | 20.39 Million AUD | 58.867% |
Proteomics International Laboratories Limited | 10.87 Million AUD | 22.867% |
CSL Limited | 56.93 Billion AUD | 99.985% |
Arovella Therapeutics Limited | 13.28 Million AUD | 36.857% |
Bio-Gene Technology Limited | 3.15 Million AUD | -165.487% |
Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 96.371% |
Starpharma Holdings Limited | 36.81 Million AUD | 77.214% |
Nanollose Limited | 241.95 Thousand AUD | -3366.938% |
Memphasys Limited | 12.43 Million AUD | 32.517% |
Invex Therapeutics Ltd | 6.12 Million AUD | -37.062% |
NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -54.314% |
Amplia Therapeutics Limited | 14.84 Million AUD | 43.495% |
Botanix Pharmaceuticals Limited | 112.46 Million AUD | 92.541% |
Island Pharmaceuticals Limited | 2.56 Million AUD | -227.096% |
Race Oncology Limited | 20.22 Million AUD | 58.532% |
Nyrada Inc. | 5.9 Million AUD | -42.0% |
Telix Pharmaceuticals Limited | 398.3 Million AUD | 97.894% |
Dimerix Limited | 32.07 Million AUD | 73.851% |
PharmAust Limited | 11.12 Million AUD | 24.599% |
Immutep Limited | 147.44 Million AUD | 94.311% |
Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 94.575% |
Alterity Therapeutics Limited | 19.22 Million AUD | 56.365% |
BTC Health Limited | 5.14 Million AUD | -62.917% |
Acrux Limited | 8.96 Million AUD | 6.412% |
Neuren Pharmaceuticals Limited | 247.97 Million AUD | 96.617% |
Biotron Limited | 493.47 Thousand AUD | -1599.837% |
Tissue Repair Ltd | 19.38 Million AUD | 56.738% |
AdAlta Limited | 5.57 Million AUD | -50.517% |
Radiopharm Theranostics Limited | 72.03 Million AUD | 88.355% |
Hexima Limited | 2.26 Million AUD | -269.69% |
AnteoTech Limited | 9.38 Million AUD | 10.584% |
Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 69.375% |
Recce Pharmaceuticals Ltd | 6.36 Million AUD | -31.692% |
Avecho Biotechnology Limited | 7.31 Million AUD | -14.605% |
Actinogen Medical Limited | 21.31 Million AUD | 60.64% |
Immuron Limited | 15.54 Million AUD | 46.056% |
Argenica Therapeutics Limited | 16.37 Million AUD | 48.782% |